EU Kills Generics Delay Probe Of AstraZeneca, Nycomed
The European Union's competition regulator said Thursday it was ending its investigation into pharmaceutical heavies AstraZeneca PLC and Nycomed, after failing to prove the companies made agreements over patents to delay...To view the full article, register now.
Already a subscriber? Click here to view full article